| Cancer biomarker discovery and validation N Goossens, S Nakagawa, X Sun, Y Hoshida Translational cancer research 4 (3), 256, 2015 | 671 | 2015 |
| Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine N Fujiwara, SL Friedman, N Goossens, Y Hoshida Journal of hepatology 68 (3), 526-549, 2018 | 611 | 2018 |
| A simple diet-and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer T Tsuchida, YA Lee, N Fujiwara, M Ybanez, B Allen, S Martins, MI Fiel, ... Journal of hepatology 69 (2), 385-395, 2018 | 453 | 2018 |
| Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma S Finkin, D Yuan, I Stein, K Taniguchi, A Weber, K Unger, JL Browning, ... Nature immunology 16 (12), 1235, 2015 | 335 | 2015 |
| IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non‐1 HCV genotypes PY Bochud, S Bibert, Z Kutalik, E Patin, J Guergnon, B Nalpas, ... Hepatology 55 (2), 384-394, 2012 | 196 | 2012 |
| Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ... Cancer cell 30 (6), 879-890, 2016 | 187 | 2016 |
| Hepatitis C virus-induced hepatocellular carcinoma N Goossens, Y Hoshida Clinical and molecular hepatology 21 (2), 105, 2015 | 186 | 2015 |
| Is genotype 3 of the hepatitis C virus the new villain? N Goossens, F Negro Hepatology 59 (6), 2403-2412, 2014 | 159 | 2014 |
| Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies D Alfaiate, S Clément, D Gomes, N Goossens, F Negro Journal of hepatology 73 (3), 533-539, 2020 | 158 | 2020 |
| Cost-effectiveness of risk score–stratified hepatocellular carcinoma screening in patients with cirrhosis N Goossens, AG Singal, LY King, KL Andersson, BC Fuchs, C Besa, ... Clinical and translational gastroenterology 8 (6), e101, 2017 | 155 | 2017 |
| Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap YA Lee, LA Noon, KM Akat, MD Ybanez, TF Lee, ML Berres, N Fujiwara, ... Nature communications 9 (1), 4962, 2018 | 136 | 2018 |
| A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection DY Zhang, N Goossens, J Guo, MC Tsai, HI Chou, C Altunkaynak, ... Gut 65 (10), 1754-1764, 2016 | 128 | 2016 |
| Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) LS Belli, C Duvoux, T Artzner, W Bernal, S Conti, PA Cortesi, SC Sacleux, ... Journal of hepatology 75 (3), 610-622, 2021 | 125 | 2021 |
| Molecular classification of hepatocellular carcinoma: potential therapeutic implications N Goossens, X Sun, Y Hoshida Hepatic oncology 2 (4), 371-379, 2015 | 117 | 2015 |
| The XBP1 arm of the unfolded protein response induces fibrogenic activity in hepatic stellate cells through autophagy RS Kim, D Hasegawa, N Goossens, T Tsuchida, V Athwal, X Sun, ... Scientific reports 6 (1), 39342, 2016 | 94 | 2016 |
| NAFLD and MAFLD as emerging causes of HCC: A populational study S Myers, I Neyroud-Caspar, L Spahr, K Gkouvatsos, E Fournier, E Giostra, ... Jhep Reports 3 (2), 100231, 2021 | 86 | 2021 |
| Clinicopathological indices to predict hepatocellular carcinoma molecular classification PS Tan, S Nakagawa, N Goossens, A Venkatesh, T Huang, SC Ward, ... Liver International 36 (1), 108-118, 2016 | 85 | 2016 |
| Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases R Bansal, S Nakagawa, S Yazdani, J Van Baarlen, A Venkatesh, AP Koh, ... Experimental & molecular medicine 49 (11), e396-e396, 2017 | 73 | 2017 |
| Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis N Lanthier, L Rubbia-Brandt, N Lin-Marq, S Clément, JL Frossard, ... Journal of hepatology 63 (3), 609-621, 2015 | 73 | 2015 |
| Using big data to discover diagnostics and therapeutics for gastrointestinal and liver diseases B Wooden, N Goossens, Y Hoshida, SL Friedman Gastroenterology 152 (1), 53-67. e3, 2017 | 71 | 2017 |
Francesco NegroProfessor, University Hospitals of Geneva在 hcuge.ch 的电子邮件经过验证
